InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Scopelianos Angelo, Directeur de la R&D. Officer active across 1 companies, notably Axogen, Inc.. Aggregated, 7 reports have been recorded. The latest transaction was filed on 16 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
011,000 shares0
Common Stock
SEC:0000805928-22-000034:0·
01,325 shares0
Common Stock
SEC:0000805928-22-000013:0·
01,325 shares0
Common Stock
SEC:0000805928-22-000013·
01,150 shares0
Common Stock
SEC:0000805928-21-000184·
01,150 shares0
Common Stock
SEC:0000805928-21-000184:0·
02,572 shares0
Common Stock
SEC:0000805928-21-000144·
02,572 shares0
Common Stock
SEC:0000805928-21-000144:0·
7 of 7 declarations
About Scopelianos Angelo
Scopelianos Angelo is Chief R&D Officer at Axogen, Inc. In this role, he is responsible for research and development of new products and technologies. His expertise in innovation and product development enables him to contribute to enhancing the solutions offered by the company. Angelo is committed to supporting Axogen's mission of improving patient outcomes.
